Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
INR 958.2
(-0.45%)
INR 958.2
(-0.45%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 201.59 Million INR | 3.79% |
| 2022 | 194.22 Million INR | -24.03% |
| 2021 | 255.66 Million INR | 12.54% |
| 2020 | 227.16 Million INR | -6.53% |
| 2019 | 243.03 Million INR | -4.16% |
| 2018 | 253.59 Million INR | 56.43% |
| 2017 | 162.11 Million INR | -26.2% |
| 2016 | 219.67 Million INR | 23.13% |
| 2015 | 178.4 Million INR | -34.92% |
| 2014 | 274.14 Million INR | 64.15% |
| 2013 | 167 Million INR | -36.5% |
| 2012 | 263.01 Million INR | 21.66% |
| 2011 | 216.17 Million INR | 1.62% |
| 2010 | 212.72 Million INR | 30.57% |
| 2009 | 162.92 Million INR | -7.01% |
| 2008 | 175.21 Million INR | -1.29% |
| 2007 | 177.49 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -1.44 Billion INR | -818.98% |
| 2023 FY | 201.59 Million INR | 3.79% |
| 2023 Q4 | 201.59 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 195.12 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 213.68 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 194.22 Million INR | 0.0% |
| 2022 FY | 194.22 Million INR | -24.03% |
| 2021 Q4 | 255.66 Million INR | 0.0% |
| 2021 Q2 | 235.2 Million INR | 0.0% |
| 2021 FY | 255.66 Million INR | 12.54% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 227.16 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 227.16 Million INR | -6.53% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 230.25 Million INR | 0.0% |
| 2019 FY | 243.03 Million INR | -4.16% |
| 2019 Q4 | 243.03 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 241.8 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 253.59 Million INR | 56.43% |
| 2018 Q4 | 253.59 Million INR | 0.0% |
| 2018 Q2 | 197.01 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 162.11 Million INR | 0.0% |
| 2017 Q2 | 185.6 Million INR | 0.0% |
| 2017 FY | 162.11 Million INR | -26.2% |
| 2016 Q2 | 169.02 Million INR | 0.0% |
| 2016 FY | 219.67 Million INR | 23.13% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 219.67 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q2 | 181.06 Million INR | 0.0% |
| 2015 FY | 178.4 Million INR | -34.92% |
| 2015 Q4 | 178.4 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 273.56 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 274.14 Million INR | 64.15% |
| 2014 Q4 | 274.14 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q4 | 167 Million INR | 0.0% |
| 2013 Q2 | 286.86 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 167 Million INR | -36.5% |
| 2013 Q3 | - INR | -100.0% |
| 2012 FY | 263.01 Million INR | 21.66% |
| 2012 Q4 | 263.01 Million INR | 0.0% |
| 2011 Q4 | 216.17 Million INR | 0.0% |
| 2011 FY | 216.17 Million INR | 1.62% |
| 2010 FY | 212.72 Million INR | 30.57% |
| 2009 FY | 162.92 Million INR | -7.01% |
| 2008 FY | 175.21 Million INR | -1.29% |
| 2007 FY | 177.49 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 159.2 Million INR | -26.625% |
| Cian Healthcare Limited | 1.03 Billion INR | 80.51% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -9373.308% |
| Colinz Laboratories Limited | 24.1 Million INR | -736.308% |
| Denis Chem Lab Limited | 289.82 Million INR | 30.443% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -1403.857% |
| Evoq Remedies Limited | 116.23 Million INR | -73.439% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -2.138% |
| MedPlus Health Services Limited | 14.27 Billion INR | 98.588% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 75.804% |
| PANJON LTD. | 25.38 Million INR | -694.201% |
| PRAVEG LIMITED | 767.53 Million INR | 73.735% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -30.005% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 86.566% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -67322.074% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -860.419% |
| BDH Industries Limited | 312.53 Million INR | 35.498% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -71.24% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 87.868% |
| Veerhealth Care Limited | 62.78 Million INR | -221.109% |
| Zenith Healthcare Limited | 24.03 Million INR | -738.743% |
| Zenlabs Ethica Limited | 301.35 Million INR | 33.105% |
| Zenotech Laboratories Limited | 156.64 Million INR | -28.691% |
| Crestchem Limited | 23.94 Million INR | -741.826% |
| Norris Medicines Limited | 278.17 Million INR | 27.53% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 0.189% |
| Sunil Healthcare Limited | 902.83 Million INR | 77.671% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 82.174% |
| Bacil Pharma Limited | 1.12 Million INR | -17755.802% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 89.169% |
| Patidar Buildcon Limited | 25.57 Million INR | -688.331% |
| Phaarmasia Limited | 211.49 Million INR | 4.682% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 58.721% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 88.24% |
| Trimurthi Limited | 101.36 Thousand INR | -198787.135% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -15.086% |
| Vivanza Biosciences Limited | 148.63 Million INR | -35.633% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -684.372% |
| Anuh Pharma Limited | 1.54 Billion INR | 86.949% |
| Beryl Drugs Limited | 85.63 Million INR | -135.406% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 79.928% |
| Deccan Health Care Limited | 111.33 Million INR | -81.066% |
| Godavari Drugs Limited | 957.86 Million INR | 78.954% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -24.69% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -2172.227% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 80.94% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 79.767% |
| Lactose (India) Limited | 536.39 Million INR | 62.417% |
| Makers Laboratories Limited | 569.18 Million INR | 64.582% |
| Medi-Caps Limited | 63.01 Million INR | -219.906% |
| Mercury Laboratories Limited | 171.18 Million INR | -17.76% |
| Parmax Pharma Limited | 117.56 Million INR | -71.469% |
| Roopa Industries Limited | 493.08 Million INR | 59.116% |
| Smruthi Organics Limited | 485.72 Million INR | 58.496% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -380.301% |
| Syschem (India) Limited | 1.07 Billion INR | 81.172% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 30.838% |
| Bharat Parenterals Limited | 2.65 Billion INR | 92.411% |
| Trident Lifeline Limited | 331.26 Million INR | 39.144% |
| Concord Drugs Limited | 249.88 Million INR | 19.326% |
| Gennex Laboratories Limited | 535.21 Million INR | 62.334% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -1245.831% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -275.775% |
| Parnax Lab Limited | 1.17 Billion INR | 82.78% |
| Trinity League India Limited | 876 Thousand INR | -22912.785% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -70.518% |
| Tyche Industries Limited | 101.64 Million INR | -98.337% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 88.254% |
| Transchem Limited | 6.72 Million INR | -2899.881% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 3.286% |
| Panchsheel Organics Limited | 340.2 Million INR | 40.743% |
| Coral Laboratories Limited | 281.83 Million INR | 28.473% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 90.133% |
| Natural Capsules Limited | 1.47 Billion INR | 86.353% |
| Auro Laboratories Limited | 433.09 Million INR | 53.453% |